Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Oncogene
|
July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation
T J Seng, J S W Low, H Li, et al.
Investigational New Drugs
|
June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
B B Y Ma, B C Goh, W T Lim, et al.
British Journal of Cancer
|
March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
S C C Wong, S S M Ng, M T Cheung, et al.
Oncogene
|
May 13, 2008
Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas
K Y Lee, H Geng, K M Ng, et al.
Cancer Chemotherapy and Pharmacology
|
June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
W Yeo, M Boyer, H C Chung, et al.
AJNR. American Journal of Neuroradiology
|
March 19, 2020
Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma
A D King, J K S Woo, Q-Y Ai, et al.
Oncogene
|
November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
V W Y Lui, E Y L Wong, K Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial
A T C Chan, P M L Teo, R K Ngan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2019
Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
A D King, J K S Woo, Q Y Ai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Oncogene
|
July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation
T J Seng, J S W Low, H Li, et al.
Investigational New Drugs
|
June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
B B Y Ma, B C Goh, W T Lim, et al.
British Journal of Cancer
|
March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
S C C Wong, S S M Ng, M T Cheung, et al.
Oncogene
|
May 13, 2008
Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas
K Y Lee, H Geng, K M Ng, et al.
Cancer Chemotherapy and Pharmacology
|
June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
W Yeo, M Boyer, H C Chung, et al.
AJNR. American Journal of Neuroradiology
|
March 19, 2020
Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma
A D King, J K S Woo, Q-Y Ai, et al.
Oncogene
|
November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
V W Y Lui, E Y L Wong, K Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial
A T C Chan, P M L Teo, R K Ngan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2019
Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
A D King, J K S Woo, Q Y Ai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Page
of 5